![Michelle Robertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 250 100 $ in data 31/05/2026
Ms. Michelle Robertson is a Chief Financial Officer, Treasurer & Executive VP at Geron Corp.
and an Independent Director at Verastem, Inc. She is on the Board of Directors at Verastem, Inc. Ms. Robertson was previously employed as a Chief Financial Officer & Treasurer by Editas Medicine, Inc., a Treasurer, Chief Financial & Accounting Officer by Momenta Pharmaceuticals, Inc., a Vice President-Oncology Finance by Baxalta, Inc., and a Head-Financial Planning & Analysis by Ironwood Pharmaceuticals, Inc. She received her undergraduate degree from Bentley University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VERASTEM, INC. 0,09% | 21/05/2026 | 52.666 ( 0,09% ) | 228 044 $ | 31/05/2026 |
| 26/03/2026 | 17.645 ( 0% ) | 22 056 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERASTEM, INC. | Direttore/Membro del Consiglio | 15/11/2021 |
| GERON CORPORATION | Direttore Finanziario/CFO | 25/09/2023 |
| Società | Posizione | Fine |
|---|---|---|
| EDITAS MEDICINE, INC. | Direttore Finanziario/CFO | 17/05/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 08/01/2020 |
| BAXALTA INC | Corporate Officer/Principal | 01/01/2016 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
